PeppiLibrary
Peptide library
Search 55 peptide references by name, alias, route, evidence, storage, and tracking context. Educational only, designed to support clinician conversations.
Pro-apoptotic peptide targeting fat-tissue vasculature. Animal-only weight-loss research.
Copper-binding tripeptide focused on hair follicle stimulation. Companion to GHK-Cu.
Synthetic fragment of human growth hormone. Researched for fat metabolism without GH effects.
EPO-derived 11-AA peptide. Anti-inflammatory and tissue-protective without erythropoietic effects.
Topical hexapeptide that blunts facial muscle contraction. 'Botox in a bottle' marketing.
Body protection compound. Researched for soft-tissue and gut-lining recovery.
Long-acting amylin analog. Often paired with semaglutide for amplified weight loss.
Porcine brain-derived peptide mixture. Approved abroad for stroke and dementia.
GHRH analog. Two variants — with or without DAC — have very different cadences.
Eight-AA fragment of ADNP. Microtubule-stabilising and neuroprotective.
Angiotensin IV analog. Reportedly potent BDNF/HGF signal in animal cognitive models.
Nine-amino-acid peptide isolated from rabbit cerebral venous blood. Sleep modulation research.
Tetrapeptide researched by Khavinson lab for telomerase activation and circadian regulation.
Topical tetrapeptide for under-eye puffiness and dark circles.
Senolytic peptide. Disrupts FOXO4-p53 binding to selectively eliminate senescent cells.
Copper tripeptide. Researched for skin remodeling, hair growth and wound healing.
Older GH secretagogue. Strong pulse but raises cortisol and prolactin.
Strong GH secretagogue with pronounced appetite stimulation.
Native GnRH decapeptide. Pulsatile dosing alternative to HCG for HPG axis support.
Glycoprotein hormone mimicking LH. Maintains testicular function during TRT.
Most potent GHRP. Cardiac protective effects studied. Tachyphylaxis warning.
Mitochondrial-derived peptide. Cytoprotective, neuroprotective, and metabolic.
Long-acting IGF-1 analog. Direct anabolic signaling at IGF-1 receptors.
Selective GH secretagogue. Cleaner pulse than older GHRPs.
C-terminal fragment of kisspeptin. Master regulator of the HPG axis. Stimulates LH/FSH.
Tripeptide fragment of α-MSH. Anti-inflammatory and gut research.
Octapeptide tight-junction modulator. Researched for celiac disease and leaky gut.
First-generation long-acting GLP-1 agonist. Daily injection.
Endogenous antimicrobial peptide. Broad-spectrum antibacterial, antiviral, immunomodulatory.
Topical lipopeptide stimulating collagen synthesis. Long-running cosmetic peptide.
Long-acting melanocortin agonist. FDA-approved as Scenesse for photoprotection.
Melanocortin agonist used for tanning and libido. Significant safety concerns.
Local IGF-1 splice variant produced by mechanically loaded muscle. Activates satellite cells.
Mitochondrial-derived peptide. Insulin sensitivity and metabolic flexibility research.
Stabilised Semax variant with longer half-life. Same BDNF/NGF mechanism.
Endogenous nonapeptide. Bonding, social cognition, labor induction.
GLP-1/glucagon dual agonist. Targets both obesity and MASH simultaneously.
Arginate-stabilised analog of BPC-157. Marketed for improved stability and shelf life.
Khavinson tripeptide. Pineal-derived bioregulator for sleep and cognitive support.
FDA-approved melanocortin agonist for premenopausal HSDD. Acute libido enhancer.
Triple agonist (GIP/GLP-1/glucagon) in late-stage trials. Most powerful weight-loss data to date.
Russian-developed anxiolytic peptide. Typically administered intranasally.
FDA-approved GLP-1 receptor agonist for type 2 diabetes and weight management.
Russian-developed nootropic peptide. BDNF/NGF upregulation. Intranasal.
GHRH analog. Stimulates the pituitary to release endogenous growth hormone.
Topical octapeptide extending the Argireline mechanism. Marketed for stronger expression-line effects.
Mitochondrial-targeted antioxidant tetrapeptide. Cardiolipin binding stabilises inner membrane.
GLP-1/glucagon dual agonist. Phase 3 in obesity and MASH.
Synthetic fragment of thymosin beta-4. Long half-life, weekly dosing.
FDA-approved GHRH analog. Specifically reduces visceral fat in HIV lipodystrophy.
Pentapeptide active fragment of thymopoietin. Immune restoration in immunocompromised states.
Naturally occurring 28-AA thymic peptide. Approved abroad for hepatitis and immune support.
Dual GIP/GLP-1 receptor agonist. Stronger weight-loss data than semaglutide.
Long-acting GnRH agonist. Initial flare then sustained HPG suppression.
Khavinson dipeptide. Immune and longevity research.
Try a broader search, clear a filter, or search by route, category, alias, or use case.
Safety first
Peptide dose, route, timing, storage, and safety decisions should be reviewed with a qualified healthcare professional. Peppi helps you organize records, reminders, vial inventory, and questions for review.